Trials / Unknown
UnknownNCT04828317
Alpha-gal Pork Challenge
Placebo Controlled Alpha-gal Pork Challenge
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study is investigating the hypothesis that alpha-gal is responsible for the gastrointestinal symptoms that occur in some alpha-gal syndrome subjects following the consumption of mammalian meat. This will be tested by comparing symptoms and immune responses in subjects with alpha-gal syndrome following consumption of "wild-type" pork (which contains alpha-gal) versus consumption of a novel pork product which has been genetically modified to lack alpha-gal (GalSafe pork from Revivicor Inc.).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pork Challenge | Double blind oral challenges comparing wild-type and alpha-gal free pork. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-04-30
- Completion
- 2024-04-30
- First posted
- 2021-04-02
- Last updated
- 2021-04-02
Source: ClinicalTrials.gov record NCT04828317. Inclusion in this directory is not an endorsement.